Le Lézard
Classified in: Health
Subject: SCZ

Healthy Aging Medical Centers' New Location Now Open in Montvale, New Jersey

MONTVALE, N.J., June 10, 2019 /PRNewswire/ -- Healthy Aging Medical Centers is pleased to announce it has opened a new location in Montvale, New Jersey. 

This Montvale, New Jersey location, located in an affluent neighborhood, offers cutting edge medical technology to allow one to achieve optimum healthy aging.  This includes Emsculpt, an FDA-approved treatment which simultaneously triggers muscle contractions while also burning stubborn fat. It is completely non-invasive, meaning no surgery needed and more importantly, no downtime.

Healthy Aging Medical Centers also offers Cryotherapy, a technology that accelerates your natural recovery, boosts metabolism, reduces pain and inflammation, and increases blood flow and circulation.  This is achieved by walking into a body sized chamber up to your neck and having liquid nitrogen mist sprayed into the air at a temperature of -220 degrees Fahrenheit.  This process only lasts a few minutes but brings skin's temperature down between 30-40 degrees.   

Their services also include IV Nutrient Therapy, which is a safe, non-invasive therapy. IV Therapy injections consist of various nutrients that have helped people strengthen their bodies while also overcoming the effects of disease.  This is a key therapy in helping people regain optimal health and wellness while making them feel rejuvenated.

Healthy Aging Medical Centers is a prestigious wellness facility led by Dr. Johanan Rand, MD in the heart of New Jersey. It has expert physicians in the field of Medical Therapy and Anti-aging whom work with cutting-edge technology for a variety of procedures to provide patients with every opportunity to obtain the best possible care and results externally and internally. There are a variety of wellness programs custom-tailored for each patient and implemented to prevent disease with the ultimate goal to allow one to age optimally. 

Dr. Johanan Rand, MD, Founder and Medical Director of Healthy Aging Medical Centers, is board certified in Anti-aging Medicine, Regenerative Medicine, Functional Medicine. Dr. Rand also has a certification in Medical Acupuncture and is also a leading expert in Platelet Rich Plasma, also known as PRP and certified in all PRP procedures to help patients with joint injections, hair, face, and sexual wellness. 

Healthy Aging Medical Center in Montvale, New Jersey offers various procedures to help patients look and feel their very best.  They offer treatment plans or procedures that work for everyone.

Media Contact:
Dr. Johanan Rand, M.D. | Medical Director
(973) 325-6400

SOURCE Healthy Aging Medical Centers

These press releases may also interest you

at 10:57
Laborie Medical Technologies (LABORIE), a leading diagnostic and therapeutic medical technology company, in partnership with Signet Healthcare Partners, a growth equity firm specializing in healthcare investments, announced the close of the...

at 10:53
A new artificial intelligence (AI)-based application promises to reinvent the revenue cycle for hospitals and healthcare organizations by building a "digital employee" that will recognize vulnerabilities in an organization's revenue cycle and reduce...

at 10:52
Reliant Funding, a leading small business finance provider, announces its most recent dual benefit program.  Combining access to funding for American Small Businesses and charitable giving.  This program will raise funds for the American Cancer...

at 10:49
In less than three years since being established, DisposeRx, Inc.'s market-leading, patented drug disposal packets are now available in all 50 states and 70% of counties across the United States....

at 10:47
FibroGenesis, the leading developer of fibroblast based therapeutic solutions for unmet medical needs has entered into a clinical collaboration agreement with Brazilian R4D Biotech. Holding the world's largest patent portfolio in the field of cell...

at 10:45
Acticor Biotech, a clinical stage biotechnology company involved in the acute phase of thrombotic diseases, including acute ischemic stroke, today announced the completion of its ACTIMIS Dose Escalation Phase of Glenzocimab Study as add-on to...

News published on 10 june 2019 at 08:43 and distributed by: